Recombinant Protein Market
Recombinant Protein Market Analysis By Product (Cytokines & Growth Factors, Antibodies), By Host Cell (Mammalian Systems, Yeast & Fungi, Bacterial Cells), By Application (Therapeutics, Research), By End Use, By Region - Global Market Insights 2022 to 2032
Analysis of Recombinant Proteins Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
FREE CustomizationRecombinant Proteins Market Outlook (2022 to 2032)
The global recombinant proteins market size was valued at US$ 457.1 Million in 2022, and is projected to reach US$ 719.5 Million by 2032, growing at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period from 2022 to 2032.
The market has contributed to 10% of the overall drug market. However, it is anticipated to capture large proportion over the forecast period.
| Report Attributes | Details |
|---|---|
| Recombinant Proteins Market Size (2021A) | US$ 437 Million |
| Estimated Market Value (2022E) | US$ 457.1 Million |
| Forecasted Market Value (2032F) | US$ 719.5 Million |
| Global Market Growth Rate (2022 to 2032) | 4.6% CAGR |
| North America Market Share (2021) | ~ 32.7% |
| Europe Market Growth Rate (2022 to 2032) | ~ 4.4% CAGR |
| United States Market Growth Rate (2022 to 2032) | ~ 5% CAGR |
| Market Share of Top 5 Companies | ~ 31.1% |
| Key Companies Profiled | A.M.S. Biotechnology (Europe) Limited; Bio-Rad Laboratories Inc.; BPS Bioscience Inc.; Abcam plc; PerkinElmer Inc.; Crown Bioscience Inc.; GenScript Corporation; Merck Millipore Limited; Sigma Aldrich Company Ltd. |
Sales Analysis of Recombinant Protein (2017 to 2021) Vs. Market Forecast Outlook (2022 to 2032)
Most human diseases are partly associated with the dysfunction of specific proteins. Thus, growing chronic diseases such as cancer, diabetes, anemia, etc., have created a path for the production of recombinant proteins. Also, augmenting focus on healthcare provides a space for innovation in biologics and biosimilars which also supports the invention in the recombinant proteins market in the past years.
Hence, the sale of recombinant protein has observed noticeable growth during the historical period representing a compound annual growth rate of 4.3%.
Furthermore, the demand for recombinant protein will observe an upward trend during the forecast period due to rising investment in R&D, and escalating demand for protein-based regenerative and therapeutic medicines around the globe.
Apart from healthcare, recombinant proteins are also used in agriculture, food production, and bioengineering which will further increase the demand in near future.
Fact.MR suggests that the global recombinant proteins market will be valued at US$ 719.5 Million by 2032 end posing a CAGR of 4.6% since 2022.
- Short Term (2022 Q2 to 2025): Growing cases of chronic diseases and unavoidable viral outbreaks will upsurge the demand for protein-based therapeutic treatments. This will upsurge the growth of the market during the short term forecast period.
- Medium Term (2025 to 2028): Rising awareness regarding the use of recombinant proteins in food production and agriculture sector will give momentum to the market growth in medium term forecast period.
- Long Term (2028 to 2032): The government spending on biotechnology for novel innovation and the production of recombinant proteins will provide long-term growth to the market.
Over the 2017 to 2021 historical period, the global recombinant proteins market registered a CAGR of 4.3%, and according to the Fact.MR, a market research and competitive intelligence provider, the market is projected to exhibit growth at 4.6% CAGR between 2022 and 2032.
Market share analysis of recombinant protein based on product type and region is provided in a nutshell in the above image. Under the product type segment, the growth factors sub-segment dominates with 21.3% market share in 2022.
What’s Driving Demand for Recombinant Protein?
“Evolving Generations of Recombinant Protein with Wide Applications Spur the Market Growth’’
Recombinant proteins are not only used in research but also used as a drug to treat various chronic diseases such as dwarfism, congestive heart failure, diabetes, cerebral apoplexy, myocardial infarction, multiple sclerosis, anemia, neutropenia, etc. There are almost more than 130 recombinant proteins that have been approved by US FDA to date. Though, more than 170 recombinant proteins are manufactured and are widely used in medicines across the world.
Moreover, recombinant protein generations came up with some improvements as compared to the previous generation. Such as first-generation recombinant proteins comprised of native structures of proteins, furthermore, the second generation encompassed proteins with enhanced properties such as specificity, biodistribution, and efficacy. Furthermore, the third generation of recombinant protein comprised new formulations and new routes of administration with higher efficacy and safety. Hence, product improvisation is the key contributor to the recombinant proteins market growth.
“Significant Rise of Research in Biologics led to Upsurge the Sale of Recombinant Proteins”
The wide growth of healthcare sector across the world supports the investment in research and development to introduce novel solutions for various diseases. The growth of recombinant proteins is directly proportional to the growth of healthcare sector and investment in biologics. Also, government funding led to amplifying the research activities in biotechnological businesses and academic institutes to bring innovations in recombinant proteins market.
The above-mentioned factors are anticipated to fuel the request for recombinant antibodies and recombinant human erythropoietin etc.
What Do Recombinant Protein Manufacturers Need to Watch Out for?
“Complexity of Protein, Its Purification and Protein Expression may Slowdown the Production”
The production of recombinant protein is a complex process owing to complex structure of a protein. For instance, the presence of GPI-anchor or transmembrane domains may mix the target proteins and plasma membranes, which reduces the yield of protein. In addition, the transmembrane is hydrophobic in nature which also disturbs the protein stability.
Additionally, aggregation and over-expression of the target protein may create unexpected physiological variations in the host cells which further results in making misfolded proteins as well as protein degradation by the enzyme protease of the host body.
Hence, process optimization and careful planning are the necessary factors in recombinant protein expression to create an appropriate host, culture duration, and condition. Thus, manufacturers need to watch out aforementioned factors to avoid hindrances in market growth.
Country-wise Insights
Will the High R&D Spending in United States Drive High Demand for Recombinant Protein?
The U.S. is anticipated to grow with a CAGR of 5% during the forecast period. The high growth of recombinant proteins market in U.S. is due to high spending on research and development, government support for innovations, and huge presence of key market players in that country.
Apart from this, the United States is a prominent country for prevalence of chronic diseases such as cancer and diabetes which makes it a noticeable country for innovations in recombinant proteins. Intensifying per capita healthcare spending is also a major factor in the growing acceptance of recombinant proteins in the U.S.
Why Recombinant Protein Market Expected to Be Highly Opportunistic in Japan?
Japan is the key contributor to the growth of the recombinant proteins market in the APAC region. The dominance is due to huge government support and the growing biotechnology industry in Japan. For instance, the government of Japan has financed Okinawa Health Biotechnology Research and Development Center, which offers free research amenities to capable biotechnology companies.
The manufacturers who are willing to invest in international markets, Japan, and Asian markets will provide incredible opportunities for collaborations and business developments.
Category-wise Insights
Which Product Type is Most Widely Used?
The recombinant protein under the product type segment is categorized into Immune checkpoint regulators, chemokines, growth factors, cytokines, colony-stimulating factors, hormones, enzymes & inhibitors, and others. Amongst them, the recombinant growth factors sub-segment holds the largest market share of 21.3% of the global market in 2021 and is expected to witness a CAGR of 4.5% during the forecast years of 2022-2032.
Recombinant growth factors have gained popularity in the market owing to their wide array of applications. Various recombinant growth factors have been verified for their capability to quicken chronic wound healing in diabetic patients. Apart from this, one of the prominent applications of recombinant growth factors in clinical nephrology. It acts as a growth hormone in children who suffer from growth failure with chronic renal failure. Hence, the wide applications of recombinant growth factors give them popularity among other recombinant proteins.
Which application is estimated to support marker growth in recombinant protein market during the forecast period?
In terms of applications, recombinant proteins are segmented into drug discovery & development, basic research, toxicity screening, biopharmaceutical production, drug screening, tissue engineering, and forensic testing. Which, the basic research segment holds the majority of the global recombinant proteins market share. It is anticipated to follow the same trend during the forecast period. The basic research segment is projected to hold 55.1% share of the market by 2032.
To clarify the fundamental and basic principle of an organism can be carried with the help of recombinant protein. They can be useful to locate and identify the location of protein determined by a specific gene and to reveal the role of other genes such as metabolism, replication, growth, translation, transcription, etc. Hence, due to the above-mentioned ability, recombinant proteins are widely used in cell biology, molecular biology, structural and biophysical studies, biochemistry, and several other research areas.
Competitive Landscape
Prominent recombinant protein manufacturers are A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc., Abcam plc, PerkinElmer Inc., Crown Bioscience Inc., GenScript Corporation, Merck Millipore Limited, Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech Inc., Thermo Fisher Scientific Inc.
Key market players are focusing on products to widen the applications of recombinant proteins in various industries by investing in R&D. Investment to bring novel products into the market is the key strategy among the market leaders. Apart from this, acquisitions, partnerships, and collaborations are some in-organic growth tactics that support maintaining their position in the market.
- In August 2022, Chinese biotechnology company Bao Pharmaceuticals reported that it had raised more than US$ 100 million in a Series B investment round. The company focuses on the commercialization of recombinant protein therapeutics and antibody drugs. The funding was meant to be used for the creation and marketing of medicines made from recombinant proteins. This round was won by Oriental Fortune Capital.
- In March 2020, AMS Biotechnology launched its recombinant protein for the detection of COVID-19 and related RNA viruses. The product launch helped the company to achieve high revenue during the pandemic period.
Fact.MR has provided detailed information about the price points of key manufacturers of recombinant protein positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Key Segments in Recombinant Protein Industry Research
-
By Product Type :
- Immune Checkpoint Regulators
- Chemokines
- Growth Factors
- Cytokines
- Colony Stimulating Factors
- Hormones
- Enzymes & Inhibitors
- Other
-
By End User :
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
-
By Application :
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
Table of Content
- 1. Market - Executive Summary
- 2. Market Overview
- 3. Market Background and Foundation Data
- 4. Global Market Value (US$ Million) Analysis and Forecast
- 5. Global Market Analysis and Forecast, By Product Type
- 5.1. Immune Checkpoint Regulators
- 5.2. Chemokines
- 5.3. Growth Factors
- 5.4. Cytokines
- 5.5. Colony Stimulating Factors
- 5.6. Hormones
- 5.7. Enzymes & Inhibitors
- 5.8. Other
- 6. Global Market Analysis and Forecast, By Application
- 6.1. Drug Discovery & Development
- 6.2. Basic Research
- 6.3. Toxicity Screening
- 6.4. Biopharmaceutical Production
- 6.5. Drug Screening
- 6.6. Tissue Engineering
- 6.7. Forensic Testing
- 7. Global Market Analysis and Forecast, By End User
- 7.1. Biopharmaceutical Companies
- 7.2. Contract Research Organizations (CROs)
- 7.3. Academic & Research Institutes
- 7.4. Forensic Science Laboratories
- 7.5. Food & Beverage Companies
- 7.6. Diagnostic Centers
- 7.7. Others
- 8. Global Market Analysis and Forecast, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & ASEAN
- 8.6. Oceania
- 8.7. Middle East & Africa
- 9. North America Market Analysis and Forecast
- 10. Latin America Market Analysis and Forecast
- 11. Europe Market Analysis and Forecast
- 12. East Asia Market Analysis and Forecast
- 13. South Asia & ASEAN Market Analysis and Forecast
- 14. Oceania Market Analysis and Forecast
- 15. Middle East & Africa Market Analysis and Forecast
- 16. Country-level Market Analysis and Forecast
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Hologic
- 18.2. Care Wise Medical Products (LabLogic Systems, Inc)
- 18.3. Devicor Medical Products, Inc.
- 18.4. Intramedical Imaging
- 18.5. Crystal Photonics GmbH
- 18.6. BIODEX
- 18.7. Oncovision
- 18.8. Capintec Inc
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
List Of Table
Table 01: Global Market Value (USD Million) and Forecast by Region, 2017 to 2021
Table 02: Global Market Value (USD Million) and Forecast by Region, 2022 to 2032
Table 03: Global Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 04: Global Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 05: Global Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 06: Global Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 07: Global Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 08: Global Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 09: North America Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 10: North America Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 11: North America Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 12: North America Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 13: North America Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 14: North America Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 15: North America Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 16: North America Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 17: Latin America Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 18: Latin America Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 19: Latin America Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 20: Latin America Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 21: Latin America Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 22: Latin America Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 23: Latin America Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 24: Latin America Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 25: Europe Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 26: Europe Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 27: Europe Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 28: Europe Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 29: Europe Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 30: Europe Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 31: Europe Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 32: Europe Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 33: East Asia Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 34: East Asia Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 35: East Asia Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 36: East Asia Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 37: East Asia Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 38: East Asia Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 39: East Asia Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 40: East Asia Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 41: South Asia & ASEAN Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 42: South Asia & ASEAN Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 43: South Asia & ASEAN Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 44: South Asia & ASEAN Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 45: South Asia & ASEAN Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 46: South Asia & ASEAN Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 47: South Asia & ASEAN Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 48: South Asia & ASEAN Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 49: Oceania Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 50: Oceania Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 51: Oceania Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 52: Oceania Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 53: Oceania Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 54: Oceania Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 55: Oceania Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 56: Oceania Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 57: MEA Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 58: MEA Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 59: MEA Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 60: MEA Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 61: MEA Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 62: MEA Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 63: MEA Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 64: MEA Market Value (USD Million) and Forecast by End User, 2022 to 2032
List Of Figures
Figure 01: Global Market Value (USD Million) Forecast, 2022 to 2032
Figure 02: Global Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 03: Global Market Value (USD Million) by Region, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Rate by Region, 2022 to 2032
Figure 05: Global Market Value (USD Million) by Product Type, 2022 & 2032
Figure 06: Global Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 07: Global Market Value (USD Million) by Application, 2022 & 2032
Figure 08: Global Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 09: Global Market Value (USD Million) by End User, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 11: North America Market Value (USD Million) Forecast, 2022 to 2032
Figure 12: North America Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 13: North America Market Value (USD Million) by Country, 2022 & 2032
Figure 14: North America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 15: North America Market Value (USD Million) by Product Type, 2022 & 2032
Figure 16: North America Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 17: North America Market Value (USD Million) by Application, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 19: North America Market Value (USD Million) by End User, 2022 & 2032
Figure 20: North America Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 21: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 22: North America Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 23: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 24: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 25: Latin America Market Value (USD Million) Forecast, 2022 to 2032
Figure 26: Latin America Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 27: Latin America Market Value (USD Million) by Country, 2022 & 2032
Figure 28: Latin America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 29: Latin America Market Value (USD Million) by Product Type, 2022 & 2032
Figure 30: Latin America Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 31: Latin America Market Value (USD Million) by Application, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 33: Latin America Market Value (USD Million) by End User, 2022 & 2032
Figure 34: Latin America Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 35: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 36: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 37: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 38: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 39: Europe Market Value (USD Million) Forecast, 2022 to 2032
Figure 40: Europe Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 41: Europe Market Value (USD Million) by Country, 2022 & 2032
Figure 42: Europe Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 43: Europe Market Value (USD Million) by Product Type, 2022 & 2032
Figure 44: Europe Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 45: Europe Market Value (USD Million) by Application, 2022 & 2032
Figure 46: Europe Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 47: Europe Market Value (USD Million) by End User, 2022 & 2032
Figure 48: Europe Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 49: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 50: Europe Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 51: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 52: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 53: East Asia Market Value (USD Million) Forecast, 2022 to 2032
Figure 54: East Asia Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 55: East Asia Market Value (USD Million) by Country, 2022 & 2032
Figure 56: East Asia Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 57: East Asia Market Value (USD Million) by Product Type, 2022 & 2032
Figure 58: East Asia Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 59: East Asia Market Value (USD Million) by Application, 2022 & 2032
Figure 60: East Asia Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 61: East Asia Market Value (USD Million) by End User, 2022 & 2032
Figure 62: East Asia Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 63: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 64: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 65: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 66: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 67: South Asia & ASEAN Market Value (USD Million) Forecast, 2022 to 2032
Figure 68: South Asia & ASEAN Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 69: South Asia & ASEAN Market Value (USD Million) by Country, 2022 & 2032
Figure 70: South Asia & ASEAN Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 71: South Asia & ASEAN Market Value (USD Million) by Product Type, 2022 & 2032
Figure 72: South Asia & ASEAN Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 73: South Asia & ASEAN Market Value (USD Million) by Application, 2022 & 2032
Figure 74: South Asia & ASEAN Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 75: South Asia & ASEAN Market Value (USD Million) by End User, 2022 & 2032
Figure 76: South Asia & ASEAN Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 77: South Asia & ASEAN Market Attractiveness Analysis by Country, 2022 to 2032
Figure 78: South Asia & ASEAN Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 79: South Asia & ASEAN Market Attractiveness Analysis by Application, 2022 to 2032
Figure 80: South Asia & ASEAN Market Attractiveness Analysis by End User, 2022 to 2032
Figure 81: Oceania Market Value (USD Million) Forecast, 2022 to 2032
Figure 82: Oceania Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 83: Oceania Market Value (USD Million) by Country, 2022 & 2032
Figure 84: Oceania Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 85: Oceania Market Value (USD Million) by Product Type, 2022 & 2032
Figure 86: Oceania Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 87: Oceania Market Value (USD Million) by Application, 2022 & 2032
Figure 88: Oceania Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 89: Oceania Market Value (USD Million) by End User, 2022 & 2032
Figure 90: Oceania Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 91: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 92: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 93: Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 94: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 95: MEA Market Value (USD Million) Forecast, 2022 to 2032
Figure 96: MEA Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 97: MEA Market Value (USD Million) by Country, 2022 & 2032
Figure 98: MEA Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 99: MEA Market Value (USD Million) by Product Type, 2022 & 2032
Figure 100: MEA Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 101: MEA Market Value (USD Million) by Application, 2022 & 2032
Figure 102: MEA Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 103: MEA Market Value (USD Million) by End User, 2022 & 2032
Figure 104: MEA Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 105: MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 106: MEA Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 107: MEA Market Attractiveness Analysis by Application, 2022 to 2032
Figure 108: MEA Market Attractiveness Analysis by End User, 2022 to 2032
- FAQs -
What is the global recombinant protein market size?
The global recombinant protein market is anticipated to be valued at US$ 457.1 million in 2022.
How is the market for recombinant protein expected to fare going forward?
Worldwide demand for recombinant protein is anticipated to reach US$ 719.5 million by 2032-end.
Which regional recombinant protein market accounts for a leading market share?
North America tops the global recombinant protein market will account for 32.7% market share in 2022.
Which product type holds the highest market share?
Growth factors by product type will account for 21.3% share of global sales in 2022.
How did the market perform over the last few years?
During 2017-2021, sales of recombinant protein increased at 4.3% CAGR.
Recombinant Protein Market